Treatment of whitish or yellowish vaginal discharge with Unani medicine Tiryaq e Reham

Clinical validation of Unani pharmacopoeial formulation Tiryaq e Reham in Sailan ur Reham (Leucorrhoea)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050475

Enrollment

384

Registered

2023-03-09

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified

Interventions

Intervention1: Tiryaq e Reham: 2 gms (semisolid) orally twice a day after meals with water for two weeks Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patients in the age group of 13-45 years. 2. Patients having excessive vaginal discharge with or without any of the following associated symptoms • Waja â??al-Zahr (Backache) • Naqahat (General Weakness)

Exclusion criteria

Exclusion criteria: 1. Patients having acute / Chronic PIDs 2. Unexplained vaginal bleeding 3. Abnormal findings on pelvic sonography 4. Systemic disease like hypertension, diabetes, heart disease, tuberculosis, 5. Severe anaemia i.e. Hemoglobin 6. Patients on Oral Contraceptives / IUDs. 7. Patients taking hormonal therapy. 8. Any abnormality on pv Examination. 9. Pregnant and lactating women.

Design outcomes

Primary

Measure	Time frame
Improvement in sign and symptoms of Sailan ur Reham (Leucorrhoea) i.e. Amount of Vaginal Discharge (scoring according to the semi quantitative method), Waja â??al-Zahr (backache), Naqahat (General Weakness) and improvement in abnormal findings of vaginal smearTimepoint: At baseline, 7th day and 14th day	—

Secondary

Measure	Time frame
Haematological and biochemical assessment for safety assessmentTimepoint: On baseline and 14th day	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026